Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RHHBY | LLY | JNJ | ABBV | NVS |
| Company | Roche Holdings Ltd ADR | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Novartis Ag ADR |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NYSE |
| Open | 54.5400 | 1,078.52 | 218.77 | 216.28 | 144.73 |
| High | 55.1300 | 1,095.48 | 222.17 | 219.05 | 146.22 |
| Low | 54.5000 | 1,071.74 | 218.10 | 214.76 | 144.45 |
| Latest | 54.7900 | 1,087.38 | 218.49 | 218.11 | 145.00 |
| Change | +0.5100 | +8.86 | +0.48 | +1.96 | -0.11 |
| % Change | +0.94% | +0.82% | +0.22% | +0.91% | -0.08% |
| Volume | 1,266,500 | 2,478,200 | 13,160,000 | 5,650,800 | 1,139,600 |
| 20-Day Average Volume | 2,495,745 | 2,568,505 | 8,190,240 | 6,228,640 | 1,439,980 |
| Previous Close | 54.2800 | 1,078.52 | 218.01 | 216.15 | 145.11 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 52.9352 | 1,070.62 | 210.58 | 223.54 | 141.37 |
| 20-Day Raw Stochastic | 91.96% | 61.63% | 82.69% | 30.10% | 87.50% |
| 20-Day Relative Strength | 70.39 | 57.71 | 66.53 | 44.78 | 65.77 |
| Weighted Alpha | +51.50 | +48.98 | +52.40 | +22.89 | +45.50 |
| Today's Opinion | 100% Buy | 96% Buy | 100% Buy | 8% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 96% Buy | 100% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.54% since 01/14/26 | +1.31% since 01/14/26 | -0.03% since 01/14/26 | -1.70% since 01/14/26 | -0.79% since 01/14/26 |
| Low | 53.3600 on 01/15/26 | 1,012.57 on 01/15/26 | 210.50 on 01/21/26 | 209.96 on 01/20/26 | 142.26 on 01/15/26 |
| High | 55.1300 on 01/22/26 | 1,095.48 on 01/22/26 | 222.17 on 01/22/26 | 223.03 on 01/15/26 | 146.22 on 01/22/26 |
| 1-Month | |||||
| %Chg | +6.62% since 12/22/25 | +1.01% since 12/22/25 | +5.39% since 12/22/25 | -4.30% since 12/22/25 | +5.94% since 12/22/25 |
| Low | 50.9000 on 01/05/26 | 1,012.57 on 01/15/26 | 200.91 on 01/05/26 | 209.96 on 01/20/26 | 135.55 on 01/05/26 |
| High | 55.1300 on 01/22/26 | 1,133.95 on 01/08/26 | 222.17 on 01/22/26 | 237.04 on 01/07/26 | 146.35 on 01/14/26 |
| 3-Month | |||||
| %Chg | +24.69% since 10/22/25 | +33.84% since 10/22/25 | +13.24% since 10/22/25 | -4.62% since 10/22/25 | +10.32% since 10/22/25 |
| Low | 40.0700 on 11/03/25 | 806.02 on 10/23/25 | 184.66 on 10/29/25 | 209.96 on 01/20/26 | 121.57 on 10/29/25 |
| High | 55.1300 on 01/22/26 | 1,133.95 on 01/08/26 | 222.17 on 01/22/26 | 239.29 on 11/13/25 | 146.35 on 01/14/26 |
| 6-Month | |||||
| %Chg | +36.19% since 07/22/25 | +40.05% since 07/22/25 | +30.11% since 07/22/25 | +16.57% since 07/22/25 | +24.11% since 07/22/25 |
| Low | 37.5100 on 08/11/25 | 623.78 on 08/08/25 | 164.23 on 07/31/25 | 186.77 on 07/23/25 | 112.34 on 08/01/25 |
| High | 55.1300 on 01/22/26 | 1,133.95 on 01/08/26 | 222.17 on 01/22/26 | 244.81 on 10/01/25 | 146.35 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 345,792,800 | 1,019,615,488 | 525,250,368 | 382,020,224 | 306,533,568 |
| Shares Outstanding, K | 6,370,538 | 945,384 | 2,409,295 | 1,767,385 | 2,112,422 |
| Annual Sales | 70,874,480,000 | 45,042,700,000 | 88,821,000,000 | 56,334,000,000 | 51,722,000,000 |
| Annual Net Income | 9,401,850,000 | 10,590,000,000 | 14,066,000,000 | 4,278,000,000 | 11,941,000,000 |
| Last Quarter Sales | N/A | 17,600,800,000 | 23,993,000,000 | 15,776,000,000 | 14,358,000,000 |
| Last Quarter Net Income | N/A | 5,582,500,000 | 5,152,000,000 | 186,000,000 | 3,928,000,000 |
| 60-Month Beta | 0.44 | 0.35 | 0.34 | 0.36 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 7.02 on 10/30/25 | 2.46 on 01/21/26 | 1.86 on 10/31/25 | 2.25 on 10/28/25 |
| Latest Earnings Date | 01/29/26 | 02/05/26 | 01/21/26 | 02/04/26 | 02/04/26 |
| Most Recent Dividend | 0.873 on 03/28/25 | 1.500 on 11/14/25 | 1.300 on 11/25/25 | 1.730 on 01/16/26 | 2.596 on 03/12/25 |
| Next Ex-Dividends Date | 03/28/25 | 02/13/26 | 02/24/26 | 01/16/26 | 03/12/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 47.35 | 21.02 | 22.65 | 16.08 |